Gold(i)-catalysed addition of alcohols to 3,3-disubstituted cyclopropenes occurs in a highly regioselective and facile manner to produce alkyl tert-allylic ethers in good yields. The reaction is tolerant of sterically hindered substituents on the cyclopropene as well as primary and secondary alcohols as nucleophiles. In this full article, we report on the substrate scope and plausible mechanism, as well as the regioselectivity issues arising from subsequent gold(i)-catalysed isomerisation of tertiary to primary allylic ethers.
A simple change of solvent allows controlled and efficient switching between oxidative Heck and conjugate addition reactions on cyclic Michael acceptor substrates, catalyzed by a cationic Pd(II) catalyst system. Both reactions are ligand- and base-free and tolerant of air and moisture, and the controlled switching sheds light on some of the factors which favor one reaction over the other.
Gold(I)‐catalyzed addition of alcohols to 3,3‐disubstituted cyclopropenes occurs in a highly regioselective and facile manner (< 10 min, 20 °C) to produce alkyl tert‐allylic ethers in good yields.
Ligand-and Base-Free Pd(II)-Catalyzed Controlled Switching Between Oxidative Heck and Conjugate Addition Reactions. -Switching between oxidative Heck and conjugated addition reaction on cyclic alkenes is achieved by a simple switch of the solvent. Both reactions are ligand-and base-free and tolerant to air and moisture. -(WALKER, S. E.; BOEHNKE, J.; GLEN, P. E.; LEVEY, S.; PATRICK, L.; JORDAN-HORE, J. A.; LEE*, A.-L.; Org. Lett. 15 (2013) 8, 1886-1889, http://dx.doi.org/10.1021/ol400539h ; Inst. Chem. Sci., Heriot-Watt Univ., Riccarton, Edinburgh EH14 4AS, UK; Eng.) -Bartels 35-082
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.